In concordance with these findings, the role of the FGFR pathway, particularly FGFR1, is implicated in cancer cell stemness in luminal A breast cancer cells, promoting palbociclib resistance through the enhancement of Akt/Erk-ER signaling [178]. The gene discussed is FGFR1; the disease is breast cancer.